Strikingly, the abundance of four types of bacteria -- low levels of Haemophilus and Porphyromonas and high levels of Leptotrichia and Fusobacterium -- could distinguish pancreatic cancer patients from healthy individuals.
Vielleicht ist dies also die Möglichkeit für die Früherkennung bei Risikogruppen (chr. Pankreatitis/Hereditäre Pankreatitis) neben bereits bestehenden Markern wie CA 19-9The research team hypothesize that the immune system is the most likely link between any confirmed shifts in the microbiome with pancreatic cancer -- for example, disease development in the pancreas may influence the immune response in ways that favour the growth of certain bacteria -- or vice versa. If proven, this could set the stage for the development of new treatment strategies involving antibiotics or immunotherapies -- or potentially even probiotics that can help prevent pancreatic cancer in high-risk patients in the future.
https://www.sciencedaily.com/releases/2 ... 191451.htm
